Citius Pharmaceuticals
CTXR
10 hedge funds and large institutions have $1.3M invested in Citius Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
85% more capital invested
Capital invested by funds: $700K → $1.3M (+$596K)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
0.14% more ownership
Funds ownership: 0.09% → 0.24% (+0.14%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.14M |
| 2 |
Renaissance Technologies
New York
|
+$78K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$14.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$14K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25K |
| 2 |
Jane Street
New York
|
-$11K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.39K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $813K | +$1.14M | +54,171 | New |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $279K | -$2.39K | -113 | -0.6% |
|
|
AWM
3
Argent Wealth Management
Waltham,
Massachusetts
| $113K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $55K | +$78K | +3,692 | New |
|
|
5
Wells Fargo
San Francisco,
California
| $11K | +$14K | +663 | +829% |
|
|
6
Northern Trust
Chicago,
Illinois
| $10K | +$14.3K | +678 | New |
|
|
RJA
7
Raymond James & Associates
St Petersburg,
Florida
| $7K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $6K | +$9K | +426 | New |
|
|
CP
9
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $1K | +$845 | +40 | New |
|
|
11
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$25K | -971 | Closed |
|
|
12
Jane Street
New York
| – | -$11K | -435 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$2K | -65 | Closed |
|
CTXR Hedge Fund Activity: Q1 2020 in Review
10 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals (CTXR) for Q1 2020, worth a combined $1.3M — up 85% from $700K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CTXR positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.14M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $25K sold.
- 10 institutional investors held Citius Pharmaceuticals (CTXR) as of Q1 2020, up from 9 in Q4 2019.
- Funds reported $1.3M of Citius Pharmaceuticals stock for Q1 2020, up 85% quarter-over-quarter.
- 5 funds opened new Citius Pharmaceuticals positions in Q1 2020 and 3 closed out, a net change of +2 holders.
- The largest Citius Pharmaceuticals buyer in Q1 2020 was Sabby Management, an estimated $1.14M added.
- The largest Citius Pharmaceuticals seller in Q1 2020 was Susquehanna International Group, an estimated $25K sold.
Based on aggregated 13F filings for Q1 2020.